Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahir Karakas

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Journal of Cardiac Failure|May 2, 2024
High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH TrialAdrien Picod, Hugo Nordin, Dominik Jarczak, et al.
Clinical Pharmacology and Therapeutics|March 8, 2022
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE StudyMichael Boettcher, Hans-Dirk Düngen, Frank Donath, et al.
BMC Medical Genetics|June 2, 2009
Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populationsMahir Karakas, Michael M Hoffmann, Caren Vollmert, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 23, 2021
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19Kevin Roedl, Dominik Jarczak, Marlene Fischer, et al.
Biomolecules|July 25, 2018
Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary SyndromeTanja Zeller, Christoph Waldeyer, Francisco Ojeda, et al.
Clinical Chemistry|June 16, 2011
Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) studyMahir Karakas, James L Januzzi, Julia Meyer, et al.
Journal of the American Heart Association|April 24, 2020
Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene StudyHenri Weidmann, Johannes H Bannasch, Christoph Waldeyer, et al.
European Journal of Clinical Investigation|September 29, 2011
TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary eventsChristian Herder, Wouter Peeters, Astrid Zierer, et al.
Plos One|January 10, 2013
A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populationsMahir Karakas, Jens Baumert, Marcus E Kleber, et al.
Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Journal of Cardiac Failure|May 2, 2024
High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH TrialAdrien Picod, Hugo Nordin, Dominik Jarczak, et al.
Clinical Pharmacology and Therapeutics|March 8, 2022
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE StudyMichael Boettcher, Hans-Dirk Düngen, Frank Donath, et al.
BMC Medical Genetics|June 2, 2009
Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populationsMahir Karakas, Michael M Hoffmann, Caren Vollmert, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 23, 2021
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19Kevin Roedl, Dominik Jarczak, Marlene Fischer, et al.
Biomolecules|July 25, 2018
Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary SyndromeTanja Zeller, Christoph Waldeyer, Francisco Ojeda, et al.
Clinical Chemistry|June 16, 2011
Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) studyMahir Karakas, James L Januzzi, Julia Meyer, et al.
Journal of the American Heart Association|April 24, 2020
Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene StudyHenri Weidmann, Johannes H Bannasch, Christoph Waldeyer, et al.
European Journal of Clinical Investigation|September 29, 2011
TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary eventsChristian Herder, Wouter Peeters, Astrid Zierer, et al.
Plos One|January 10, 2013
A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populationsMahir Karakas, Jens Baumert, Marcus E Kleber, et al.
Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.
Pageof 12